TRIMTECH Therapeutics
Develops small molecule therapies to degrade protein aggregates in neurodegenerative diseases
$47MSeed+
Role not disclosedActivity from announced rounds
Develops small molecule therapies to degrade protein aggregates in neurodegenerative diseases